Citations (146)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jennifer Jones, Anthony Lembo, Joel Heidelbaugh, Louis Kuritzky & Brian Lacy. (2021) Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Current Medical Research and Opinion 37:4, pages 567-578.
Read now
Read now
Anna Zielińska, Maciej Sałaga, Marcin Włodarczyk & Jakub Fichna. (2018) Chronic abdominal pain in irritable bowel syndrome – current and future therapies. Expert Review of Clinical Pharmacology 11:7, pages 729-739.
Read now
Read now
Brian E Lacy. (2016) Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. International Journal of General Medicine 9, pages 7-17.
Read now
Read now
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli & Antonio Gasbarrini. (2016) Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 17:10, pages 1395-1402.
Read now
Read now
Simona Deiana, Tommaso Gabbani, Siro Bagnoli & Vito Annese. (2015) Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opinion on Emerging Drugs 20:2, pages 247-261.
Read now
Read now
Michael Camilleri. (2013) Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 14:9, pages 1151-1160.
Read now
Read now
Sylvie Bradesi, Kirsten Tillisch & Emeran Mayer. (2006) Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 11:2, pages 293-313.
Read now
Read now
Jong H Nam, Zaid Alnoah, Sudha R Yenumula & Sreekant Murthy. (2003) Epidemiology, pathogenesis and treatment of irritable bowel syndrome. Expert Opinion on Therapeutic Patents 13:8, pages 1213-1267.
Read now
Read now
Ashkan Farhadi, Keith Bruninga, Jeremy Fields & Ali Keshavarzian. (2001) Irritable bowel syndrome: an update on therapeutic modalities. Expert Opinion on Investigational Drugs 10:7, pages 1211-1222.
Read now
Read now
Articles from other publishers (137)
David Dahlgren & Per M. Hellström. (2023) Medicinal grade opium tincture for severe diarrhea: effect revisited in observational study. Current Opinion in Gastroenterology.
Crossref
Crossref
David Gunn, Rabia Topan, Lorna Barnard, Ron Fried, Ivana Holloway, Richard Brindle, Maura Corsetti, Mark Scott, Adam Farmer, Kapil Kapur, David Sanders, Maria Eugenicos, Nigel Trudgill, Peter Whorwell, John Mclaughlin, Ayesha Akbar, Lesley Houghton, Phil G. Dinning, Qasim Aziz, Alexander C. Ford, Amanda J. Farrin & Robin Spiller. (2023)
Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The
TRITON
trial
. Alimentary Pharmacology & Therapeutics 57:11, pages 1258-1271.
Crossref
Crossref
Md. Khalid Anwer, Mohammed Muqtader Ahmed, Mohammed F. Aldawsari, Muzaffar Iqbal, Gamal A. Soliman & Ibrahim A. Aljuffali. (2023) Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box–Behnken Design, and Anti-Diarrheal Activity. Pharmaceutics 15:5, pages 1460.
Crossref
Crossref
Michael Camilleri & Saam Dilmaghani. (2023) Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review. Pharmacology & Therapeutics 245, pages 108400.
Crossref
Crossref
Uday C. Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, Arun Karyampudi, Uzma Mustafa, Philip Abraham, Chetan B. Bhatt, Karmabir Chakravartty, Sujit Chaudhuri, Omesh Goyal, Govind K. Makharia, Manas Kumar Panigrahi, Prasanta Kumar Parida, Sudhanshu Patwari, Rajesh Sainani, Shine Sadasivan, M. Srinivas, Rajesh Upadhyay & Jayanthi Venkataraman. (2023) Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 42:2, pages 249-273.
Crossref
Crossref
Christoffer S. Graven-Nielsen, Cecilie S. Knoph, Tina Okdahl, Katrine L. Høyer, Klaus Krogh, Per M. Hellström & Asbjørn M. Drewes. (2023) Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans—A Systematic Review and Treatment Guideline. Journal of Clinical Medicine 12:7, pages 2488.
Crossref
Crossref
Karolina Anderle, Michael Wolzt, Gabriele Moser, Bettina Keip, Johannes Peter, Claudia Meisslitzer, Ghazaleh Gouya, Michael Freissmuth & Cornelius Tschegg. (2022) Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial. World Journal of Gastroenterology 28:46, pages 6573-6588.
Crossref
Crossref
Stefan Müller-Lissner, Viola Andresen, Maura Corsetti, Luis Bustos Fernández, Sylvie Forestier, Fabio Pace & Miguel A. Valdovinos. (2022) Functional Abdominal Cramping Pain. Journal of Clinical Gastroenterology 56:10, pages 844-852.
Crossref
Crossref
Baha Moshiree, Joel J. Heidelbaugh & Gregory S. Sayuk. (2022) A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers. Advances in Therapy 39:9, pages 4003-4020.
Crossref
Crossref
Richard Garfinkle & Marylise Boutros. (2022) Low Anterior Resection Syndrome: Predisposing Factors and Treatment. Surgical Oncology 43, pages 101691.
Crossref
Crossref
S Kindt, H Louis, H De Schepper, J Arts, P Caenepeel, D De Looze, A Gerkens, T Holvoet, P Latour, T Mahler, F Mokaddem, S Nullens, H Piessevaux, P Poortmans, G Rasschaert, M Surmont, H Vafa, K Van Malderen, T Vanuytsel, F Wuestenberghs & J Tack. (2022) Belgian consensus on irritable bowel syndrome. Acta Gastro Enterologica Belgica 85:2, pages 360-382.
Crossref
Crossref
Amal Mohamed Elhusein & Hammad Ali Fadlalmola. (2022) Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients. Gastroenterology Nursing 45:1, pages 11-20.
Crossref
Crossref
O. N. Minushkin, L. V. Maslovsky, M. D. Ardatskaya, M. I. Bulanova, N. I. Beilina, A. M. Kolodkin, I. V. Zverkov & E. S. Gordienko. (2021) Clinical and metabolic effects of metaprebiotic therapy for some functional bowel diseases. Experimental and Clinical Gastroenterology:10, pages 100-108.
Crossref
Crossref
Judy Nee & Anthony Lembo. (2021) Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M). Alimentary Pharmacology & Therapeutics 54:S1.
Crossref
Crossref
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld & T. Wedel. (2021) Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 59:12, pages 1323-1415.
Crossref
Crossref
Gregory S. Sayuk. (2021) Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:3, pages 611-637.
Crossref
Crossref
Edith Pérez de Arce, Rodrigo Quera & Eamonn M.M. Quigley. (2021) The Dilemma of Persistent Irritable Bowel Syndrome Symptoms in Patients with Quiescent Inflammatory Bowel Disease. Gastroenterology Clinics of North America 50:3, pages 689-711.
Crossref
Crossref
Susrutha Puthanmadhom Narayanan, Bradley Anderson & Adil E. Bharucha. (2021) Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders. Mayo Clinic Proceedings 96:4, pages 1071-1089.
Crossref
Crossref
Sarvee MoosaviMark PimentelMelissa S. WongAli Rezaie. (2021) Irritable Bowel Syndrome in Pregnancy. American Journal of Gastroenterology 116:3, pages 480-490.
Crossref
Crossref
Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa & Kazuhiko Koike. (2021) Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. Journal of Gastroenterology 56:3, pages 193-217.
Crossref
Crossref
Xia Li, Bo Li, Jiaqi Zhang, Ting Chen, Haomeng Wu, Xiaoshuang Shi, Jinxin Ma, Jinyan Qin, Xudong Tang & Fengyun Wang. (2021) Efficacy of opioid receptor modulators in patients with irritable bowel syndrome. Medicine 100:4, pages e24361.
Crossref
Crossref
O. N. Minushkin, L. V. Maslovskiy, M. I. Bulanova, E. S. Gordienko, T. B. Topchiy & N. I. Beylina. (2020) Experience of using metaprebiotics in the treatment of certain functional gastrointestinal disorders. Meditsinskiy sovet = Medical Council:15, pages 105-111.
Crossref
Crossref
Sailaja Pisipati, Bradley A. Connor & Mark S. Riddle. (2020) Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome. Current Opinion in Infectious Diseases 33:5, pages 411-418.
Crossref
Crossref
Lauren Stemboroski & Ron Schey. (2020) Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel Syndrome. Gastroenterology Clinics of North America 49:3, pages 607-621.
Crossref
Crossref
May Y W Wong, Geoffrey Hebbard, Peter R Gibson & Rebecca E Burgell. (2020) Chronic constipation and abdominal pain: Independent or closely interrelated symptoms?. Journal of Gastroenterology and Hepatology 35:8, pages 1294-1301.
Crossref
Crossref
Imke Masuy, Jasper Pannemans & Jan Tack. (2020) Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterologica e Dietologica 66:2.
Crossref
Crossref
Ana Isabel Ferreira, Mónica Garrido & Fernando Castro-Poças. (2020) Irritable Bowel Syndrome: News from an Old Disorder. GE - Portuguese Journal of Gastroenterology 27:4, pages 255-268.
Crossref
Crossref
Rachel Vanderberg, Amy D. Lu & Jana G. Hashash. 2020. Sex- and Gender-Based Women's Health. Sex- and Gender-Based Women's Health
417
428
.
Christopher N Andrews & Marc Bradette. (2019) Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update. Journal of the Canadian Association of Gastroenterology.
Crossref
Crossref
David Gunn, Ron Fried, Rabia Lalani, Amanda Farrin, Ivana Holloway, Tom Morris, Catherine Olivier, Rachael Kearns, Maura Corsetti, Mark Scott, Adam Farmer, Anton Emmanuel, Peter Whorwell, Yan Yiannakou, David Sanders, John Mclaughlin, Kapil Kapur, Maria Eugenicos, Ayesha Akbar, Nigel Trudgill, Lesley Houghton, Phil G. Dinning, Alexander C. Ford, Qasim Aziz & Robin Spiller. (2019) Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial. Trials 20:1.
Crossref
Crossref
Nazanin Momeni Roudsari, Naser-Aldin Lashgari, Saeideh Momtaz, Mohammad Hosein Farzaei, André M. Marques & Amir Hossein Abdolghaffari. (2019) Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review. DARU Journal of Pharmaceutical Sciences 27:2, pages 755-780.
Crossref
Crossref
Darren M. Brenner, Gregory S. Sayuk, Catherine R. Gutman, Esther Jo, Steven J. R. Elmes, Louis W. C. Liu & Brooks D. Cash. (2019) Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study. American Journal of Gastroenterology 114:9, pages 1502-1511.
Crossref
Crossref
Kok Ann Gwee, Sutep Gonlachanvit, Uday C Ghoshal, Andrew S B Chua, Hiroto Miwa, Justin Wu, Young-Tae Bak, Oh Young Lee, Ching-Liang Lu, Hyojin Park, Minhu Chen, Ari F Syam, Philip Abraham, Jose Sollano, Chi-Sen Chang, Hidekazu Suzuki, Xiucai Fang, Shin Fukudo, Myung-Gyu Choi, Xiaohua Hou & Michio Hongo. (2019) Second Asian Consensus on Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 25:3, pages 343-362.
Crossref
Crossref
Paul Moayyedi, Christopher N Andrews, Glenda MacQueen, Christina Korownyk, Megan Marsiglio, Lesley Graff, Brent Kvern, Adriana Lazarescu, Louis Liu, William G Paterson, Sacha Sidani & Stephen Vanner. (2019) Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Journal of the Canadian Association of Gastroenterology 2:1, pages 6-29.
Crossref
Crossref
Jean-Frederic Colombel, Andrea Shin & Peter R. Gibson. (2019) AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clinical Gastroenterology and Hepatology 17:3, pages 380-390.e1.
Crossref
Crossref
Jae Hak KimSam Ryong Jee. (2019) Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 73:2, pages 84.
Crossref
Crossref
David J. Cangemi & Brian E. Lacy. (2019) Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions. Therapeutic Advances in Gastroenterology 12, pages 175628481987895.
Crossref
Crossref
Sakteesh V. Gurunathan & Madhusudan Grover. 2019. Gastrointestinal Diseases and their Associated Infections. Gastrointestinal Diseases and their Associated Infections
85
95
.
Fermín Mearin, Enrique Rey & Cecilio Santander. (2018) Síndrome del intestino irritable: cómo mejorar la toma de decisiones en la práctica clínica. Medicina Clínica 151:12, pages 489-497.
Crossref
Crossref
Fermín Mearin, Enrique Rey & Cecilio Santander. (2018) Irritable bowel syndrome: How to improve decision making in clinical practice. Medicina Clínica (English Edition) 151:12, pages 489-497.
Crossref
Crossref
Michael Camilleri. (2018) Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings 93:12, pages 1858-1872.
Crossref
Crossref
J Pannemans & M Corsetti. (2018) Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?. Current Opinion in Pharmacology 43, pages 53-58.
Crossref
Crossref
John F. Jarrell, George A. Vilos, Catherine Allaire, Susan Burgess, Claude Fortin, Robert Gerwin, Louise Lapensée, Robert H. Lea, Nicholas A. Leyland, Paul Martyn, Hassan Shenassa & Paul Taenzer. (2018) No 164 - Directive clinique de consensus pour la prise en charge de la douleur pelvienne chronique. Journal of Obstetrics and Gynaecology Canada 40:11, pages e788-e836.
Crossref
Crossref
John F. Jarrell, George A. Vilos, Catherine Allaire, Susan Burgess, Claude Fortin, Robert Gerwin, Louise Lapensee, Robert H. Lea, Nicholas A. Leyland, Paul Martyn, Hassan Shenassa & Paul Taenzer. (2018) No. 164-Consensus Guidelines for the Management of Chronic Pelvic Pain. Journal of Obstetrics and Gynaecology Canada 40:11, pages e747-e787.
Crossref
Crossref
Mengdi Jia, Xiaofang Lu, Zhengfang Wang, Luqing Zhao & Shengsheng Zhang. (2018) Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility. Journal of Neurogastroenterology and Motility 24:3, pages 479-489.
Crossref
Crossref
Kyung Ho Song, Hye-Kyung Jung, Hyun Jin Kim, Hoon Sup Koo, Yong Hwan Kwon, Hyun Duk Shin, Hyun Chul Lim, Jeong Eun Shin, Sung Eun Kim, Dae Hyeon Cho, Jeong Hwan Kim & Hyun Jung Kim. (2018) Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility 24:2, pages 197-215.
Crossref
Crossref
Victor Chedid, Priya Vijayvargiya & Michael Camilleri. (2018) Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clinical Gastroenterology and Hepatology 16:3, pages 336-338.
Crossref
Crossref
A. Wasilewski, A. Misicka, M. Sacharczuk & J. Fichna. (2018) Prosecretory effect of loperamide in ileal and colonic mucosae of mice displaying high or low swim stress-induced analgesia associated with high and low endogenous opioid system activity. Neurogastroenterology & Motility 30:2, pages e13166.
Crossref
Crossref
Orla Craig. (2018) New therapies in Irritable Bowel Syndrome. Current Opinion in Gastroenterology 34:1, pages 50-56.
Crossref
Crossref
Kenneth Barshop & Kyle Staller. (2017) Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy. Therapeutic Advances in Chronic Disease 8:11, pages 153-160.
Crossref
Crossref
Yeong Yeh Lee, Chandramouli Annamalai & Satish S. C. Rao. (2017) Post-Infectious Irritable Bowel Syndrome. Current Gastroenterology Reports 19:11.
Crossref
Crossref
Michael Camilleri & Alexander Ford. (2017) Pharmacotherapy for Irritable Bowel Syndrome. Journal of Clinical Medicine 6:11, pages 101.
Crossref
Crossref
Brian E Lacy, William D Chey, Brooks D Cash, Anthony J Lembo, Leonard S Dove & Paul S Covington. (2017) Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. American Journal of Gastroenterology 112:6, pages 924-932.
Crossref
Crossref
V. Schindler & D. Pohl. (2017) Medikamentöse Therapien bei Reizmagen und ReizdarmDrug therapy for functional dyspepsia and irritable bowel syndrome. Der Gastroenterologe 12:2, pages 135-140.
Crossref
Crossref
Susan Lucak, Lin Chang, Albena Halpert & Lucinda A. Harris. (2016) Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therapeutic Advances in Gastroenterology 10:2, pages 253-275.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
Chan Hyuk Park & Dong Soo Han. (2017) Pharmacotherapy of irritable bowel syndrome. Journal of the Korean Medical Association 60:1, pages 57.
Crossref
Crossref
Isabel Vera & F. Javier Júdez. (2017) Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Kamesh Gupta, Harparam Singh Ghuman & Shivani Vijay Handa. (2017) Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile. Clinical Medicine Insights: Gastroenterology 10, pages 117955221772890.
Crossref
Crossref
Miguel Saps & Adrian Miranda. 2017. Gastrointestinal Pharmacology. Gastrointestinal Pharmacology
147
176
.
Rena K. Fox & Thiruvengadam Muniraj. (2016) Pharmacologic Therapies in Gastrointestinal Diseases. Medical Clinics of North America 100:4, pages 827-850.
Crossref
Crossref
Brian E. Lacy, Fermín Mearin, Lin Chang, William D. Chey, Anthony J. Lembo, Magnus Simren & Robin Spiller. (2016) Bowel Disorders. Gastroenterology 150:6, pages 1393-1407.e5.
Crossref
Crossref
Paul Enck, Qasim Aziz, Giovanni Barbara, Adam D. Farmer, Shin Fukudo, Emeran A. Mayer, Beate Niesler, Eamonn M. M. Quigley, Mirjana Rajilić-Stojanović, Michael Schemann, Juliane Schwille-Kiuntke, Magnus Simren, Stephan Zipfel & Robin C. Spiller. (2016) Irritable bowel syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Anthony J. Lembo, Brian E. Lacy, Marc J. Zuckerman, Ron Schey, Leonard S. Dove, David A. Andrae, J. Michael Davenport, Gail McIntyre, Rocio Lopez, Lisa Turner & Paul S. Covington. (2016) Eluxadoline for Irritable Bowel Syndrome with Diarrhea. New England Journal of Medicine 374:3, pages 242-253.
Crossref
Crossref
Robin Spiller. (2016) Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research 5, pages 780.
Crossref
Crossref
B. E. Lacy. (2016) Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. Neurogastroenterology & Motility 28:1, pages 26-35.
Crossref
Crossref
Gregory S. Sayuk & C. Prakash Gyawali. (2015) Irritable Bowel Syndrome: Modern Concepts and Management Options. The American Journal of Medicine 128:8, pages 817-827.
Crossref
Crossref
Fred M. Howard & Miya P. Yamamoto. 2015. Clinical Gynecology. Clinical Gynecology
51
74
.
. 2015. Clinical Gynecology. Clinical Gynecology
1
202
.
Azadeh Rezvan, Sharon Jakus-Waldman, Maher A. Abbas, Tajnoos Yazdany & John Nguyen. (2015) Review of the Diagnosis, Management and Treatment of Fecal Incontinence. Female Pelvic Medicine & Reconstructive Surgery 21:1, pages 8-17.
Crossref
Crossref
Justin Sirianni, Mohab Ibrahim & Amol Patwardhan. 2015. Molecular and Cell Biology of Pain. Molecular and Cell Biology of Pain
565
611
.
Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Kentaro Sugano & Tooru Shimosegawa. (2014) Evidence-based clinical practice guidelines for irritable bowel syndrome. Journal of Gastroenterology 50:1, pages 11-30.
Crossref
Crossref
Christopher T. McNabb, Michelle M. White, Amber L. Harris & Perry N. Fuchs. (2014) The elusive rat model of conditioned placebo analgesia. Pain 155:10, pages 2022-2032.
Crossref
Crossref
Jose L. Barboza, Nicholas J. Talley & Baharak Moshiree. (2014) Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome. Drugs 74:16, pages 1849-1870.
Crossref
Crossref
H. L. DuPont. (2014) Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 39:10, pages 1033-1042.
Crossref
Crossref
Rosa LS Soares. (2014) Irritable bowel syndrome: A clinical review. World Journal of Gastroenterology 20:34, pages 12144.
Crossref
Crossref
Katy E. Trinkley & Milap C. Nahata. (2014) Medication Management of Irritable Bowel Syndrome. Digestion 89:4, pages 253-267.
Crossref
Crossref
Brian E. Lacy & Tracia OʼShana. (2014) Clinical Pearls for Irritable Bowel Syndrome. Gastroenterology Nursing 37:6, pages 392-405.
Crossref
Crossref
Magnus Simrén & Hans TörnblomEleni Athanasakos & Anton Emmanuel. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
171
193
.
Magnus Simrén & Hans TörnblomMichael Camilleri. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
105
129
.
Hans Törnblom & Magnus Simrén. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome
277
299
.
Natasha A. Koloski & Nicholas J. Talley. 2013. Women and Health. Women and Health
1353
1365
.
Ulrike Voß, Anne Lewerenz & Karen Nieber. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology
473
497
.
Stacy Menees, Richard Saad & William D. Chey. (2012) Agents that act luminally to treat diarrhoea and constipation. Nature Reviews Gastroenterology & Hepatology 9:11, pages 661-674.
Crossref
Crossref
Thomas Shima. (2012) Diagnosis and management of irritable bowel syndrome. Osteopathic Family Physician 4:6, pages 172-175.
Crossref
Crossref
Arnold Wald. (2012) Irritable bowel syndrome – Diarrhoea. Best Practice & Research Clinical Gastroenterology 26:5, pages 573-580.
Crossref
Crossref
Robin Spiller & Ching Lam. (2012) An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. Journal of Neurogastroenterology and Motility 18:3, pages 258-268.
Crossref
Crossref
Viola Andresen, Jutta Keller, Christian Pehl, Michael Schemann, Jan Preiss & Peter Layer. (2011) Irritable Bowel Syndrome. Deutsches Ärzteblatt international.
Crossref
Crossref
William D. Chey, Monthira Maneerattaporn & Richard Saad. (2011) Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome. Gut and Liver 5:3, pages 253-266.
Crossref
Crossref
K. E. Trinkley & M. C. Nahata. (2011) Treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 275-282.
Crossref
Crossref
Richard J. Saad. (2011) Peripherally Acting Therapies for the Treatment of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 40:1, pages 163-182.
Crossref
Crossref
Joong Goo KwonKyung Sik ParkJung Ho ParkJae Myung ParkCheol Hee ParkKwang Jae LeeHyo-Jin ParkJong Chul Rhee. (2011) Guidelines for the Treatment of Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 57:2, pages 82.
Crossref
Crossref
Sarah Khan & Lin Chang. (2010) Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 7:10, pages 565-581.
Crossref
Crossref
Kok-Ann Gwee, Young-Tae Bak, Uday Chand Ghoshal, Sutep Gonlachanvit, Oh Young Lee, Kwong Ming Fock, Andrew Seng Boon Chua, Ching-Liang Lu, Khean-Lee Goh, Chomsri Kositchaiwat, Govind Makharia, Hyo-Jin Park, Full-Young Chang, Shin Fukudo, Myung-Gyu Choi, Shobna Bhatia, Meiyun Ke, Xiaohua Hou & Michio Hongo. (2010) Asian consensus on irritable bowel syndrome. Journal of Gastroenterology and Hepatology 25:7, pages 1189-1205.
Crossref
Crossref
Nicholas J. Talley. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
2091
2104.e6
.
Arnold Wald. 2011. Diarrhea. Diarrhea
325
339
.
Brian E. Lacy, Kirsten Weiser & Ryan De Lee. (2009) Review: The treatment of irritable bowel syndrome. Therapeutic Advances in Gastroenterology 2:4, pages 221-238.
Crossref
Crossref
Takuya Hirata, Toshiyuki Funatsu, Yoshihiro Keto, Shinobu Akuzawa, Hiraku Akiho, Akito Nishida, Masao Sasamata & Keiji Miyata. (2009) Pharmacological and clinical profile of ramosetron hydrochloride (Irribow®), a novel therapeutic agent for irritable bowel syndrome with diarrhea. Folia Pharmacologica Japonica 133:5, pages 281-291.
Crossref
Crossref
Viola Andresen, Victor M. Montori, Jutta Keller, Colin P. West, Peter Layer & Michael Camilleri. (2008) Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Gastroenterology and Hepatology 6:5, pages 545-555.
Crossref
Crossref
Christopher W Hammerle & Christina M Surawicz. (2008) Updates on treatment of irritable bowel syndrome. World Journal of Gastroenterology 14:17, pages 2639.
Crossref
Crossref
Tom Kraft & David Kraft. (2007) Irritable bowel syndrome: symptomatic treatment versus integrative psychotherapy. Contemporary Hypnosis 24:4, pages 161-177.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
C. L. FRISSORA & B. D. CASH. (2007) Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 25:11, pages 1271-1281.
Crossref
Crossref
Michael J.G. Farthing. (2007) The patient with refractory diarrhoea. Best Practice & Research Clinical Gastroenterology 21:3, pages 485-501.
Crossref
Crossref
Fermín Mearin. (2007) Tratamiento farmacológico del síndrome del intestino irritable: una necesidad no cubierta. Gastroenterología y Hepatología 30:3, pages 130-137.
Crossref
Crossref
M. A. KAMM, C. C. JORDAN, B. R. LEAKER, F. B. NICHOLSON, C. D. R. MURRAY, S. TAYLOR, M. MARSHALL, A. GIBBS, E. G. CARTER & A. V. EMMANUEL. (2007) Pharmacological modulation of gut mucosal and large vessel blood flow. Alimentary Pharmacology & Therapeutics 25:6, pages 693-702.
Crossref
Crossref
Revital Kariv, Elisa Tiomny, Roman Grenshpon, Roy Dekel, Galit Waisman, Yehuda Ringel & Zamir Halpern. (2006) Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study. Digestive Diseases and Sciences 51:12, pages 2128-2133.
Crossref
Crossref
Mihaela Podovei & Braden Kuo. (2006) Irritable Bowel Syndrome: A Practical Review. Southern Medical Journal 99:11, pages 1235-1242.
Crossref
Crossref
H. Mönnikes, M. Schmidtmann & I. R. van der Voort. (2006) Arzneimitteltherapie des ReizdarmsyndromsDrug therapy for irritable bowel syndrome. Der Internist 47:10, pages 1073-1083.
Crossref
Crossref
Susan Roberts & Mary Krystofiak Russell. 2006. Integrating Therapeutic and Complementary Nutrition. Integrating Therapeutic and Complementary Nutrition.
Wai K Leung, Justin CY Wu, SM Liang, LS Chan, Francis KL Chan, He Xie, Sara SL Fung, Aric J Hui, Vincent WS Wong, Chun-Tao Che & Joseph JY Sung. (2006) Treatment of Diarrhea-Predominant Irritable Bowel Syndrome with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Trial. The American Journal of Gastroenterology 101:7, pages 1574-1580.
Crossref
Crossref
J. TACK, M. FRIED, L. A. HOUGHTON, J. SPICAK & G. FISHER. (2006) Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Alimentary Pharmacology and Therapeutics 24:2, pages 183-205.
Crossref
Crossref
Howard Y. Chang, Eoin C. Kelly & Anthony J. Lembo. (2006) Current gut-directed therapies for irritable bowel syndrome. Current Treatment Options in Gastroenterology 9:4, pages 314-323.
Crossref
Crossref
Michael J. G. Farthing. (2005) Functional diarrhea. Current Gastroenterology Reports 7:5, pages 350-357.
Crossref
Crossref
. (2005) Directive clinique de consensus pour la prise en charge de la douleur pelvienne chronique. Journal of Obstetrics and Gynaecology Canada 27:8, pages 802-826.
Crossref
Crossref
. (2005) Consensus Guidelines for the Management of Chronic Pelvic Pain. Journal of Obstetrics and Gynaecology Canada 27:8, pages 781-801.
Crossref
Crossref
s. m. patel, w. b. stason, a. legedza, s. m. ock, t. j. kaptchuk, l. conboy, k. canenguez, j. k. park, e. kelly, e. jacobson, c. e. kerr & a. j. lembo. (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis1. Neurogastroenterology and Motility 17:3, pages 332-340.
Crossref
Crossref
Philip Schoenfeld. (2005) Efficacy of Current Drug Therapies in Irritable Bowel Syndrome: What Works and Does Not Work. Gastroenterology Clinics of North America 34:2, pages 319-335.
Crossref
Crossref
S. D. Kuiken, G. N. Tytgat & G. E. Boeckxstaens. (2005) Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders - the clinical evidence. Alimentary Pharmacology and Therapeutics 21:6, pages 633-651.
Crossref
Crossref
D. Lesbros‐Pantoflickova, P. Michetti, M. Fried, C. Beglinger & A. L. Blum. (2004) Meta‐analysis: the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 20:11-12, pages 1253-1269.
Crossref
Crossref
Michael J.G. Farthing. (2004) Treatment options in irritable bowel syndrome. Best Practice & Research Clinical Gastroenterology 18:4, pages 773-786.
Crossref
Crossref
Robin Spiller. 2004. Pathophysiology of the Enteric Nervous System. Pathophysiology of the Enteric Nervous System
188
200
.
Nicholas J. Talley. (2003) Evaluation of drug treatment in irritable bowel syndrome. British Journal of Clinical Pharmacology 56:4, pages 362-369.
Crossref
Crossref
Driss Berrada, Katia Canenguez & Tony Lembo. (2003) New approaches to the medical treatment of irritable bowel syndrome. Current Gastroenterology Reports 5:4, pages 337-342.
Crossref
Crossref
Fred M. Howard. (2003) Chronic Pelvic Pain. Obstetrics & Gynecology 101:3, pages 594-611.
Crossref
Crossref
Amir Garakani, Terrance Win, Subhdeep Virk, Sanjay Gupta, David Kaplan & Prakash S. Masand. (2003) Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review. American Journal of Therapeutics 10:1, pages 61-67.
Crossref
Crossref
J. G. Rosemore & Brian E. Lacy. (2002) Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 35:Supplement, pages S37-S44.
Crossref
Crossref
Michael A Pezzone & Arnold Wald. (2002) Functional bowel disorders in inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 347-357.
Crossref
Crossref
Richard B Birrer. (2002) Irritable bowel syndrome. Disease-a-Month 48:2, pages 101-143.
Crossref
Crossref
Michael Camilleri. (2001) Management of the irritable bowel syndrome. Gastroenterology 120:3, pages 652-668.
Crossref
Crossref
Rebecca C. Dunphy & G. Nicholas Verne. (2001) Drug Treatment Options for Irritable Bowel Syndrome. Drugs & Aging 18:3, pages 201-211.
Crossref
Crossref
Robin D. Rothstein. (2000) IRRITABLE BOWEL SYNDROME. Medical Clinics of North America 84:5, pages 1247-1257.
Crossref
Crossref
G. Ragnarsson & G. Bodemar. (2001) Treatment of irritable bowel syndrome with loperamide oxide. An open study to determine optimal dosage. Journal of Internal Medicine 248:2, pages 165-166.
Crossref
Crossref
Shannon M. Turner, Joan E. Stewart, Jenny J. Alexopulos & Jimmie S. Hill. (2000) Irritable bowel syndrome. Current Review of Pain 4:1, pages 54-59.
Crossref
Crossref
Jeffrey L Jackson, Patrick G O’Malley, Glen Tomkins, Erin Balden, James Santoro & Kurt Kroenke. (2000) Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis11The opinions in this article represent those of the authors and are not to be construed, in any way, to represent those of the U.S. Army or the Department of Defense.. The American Journal of Medicine 108:1, pages 65-72.
Crossref
Crossref
NICHOLAS J. TALLEY & NATASHA KOLOSKI. 2000. Women and Health. Women and Health
1098
1109
.
Robin C Spiller. (1999) Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. The American Journal of Medicine 107:5, pages 91-97.
Crossref
Crossref